Abstract
In a 12-week placebo-controlled study of fluoxetine in the treatment of body dysmorphic disorder, the authors investigated change in psychosocial functioning and mental health-related quality of life in 60 subjects. The subjects were assessed with the LIFE-RIFT (a measure of impaired functioning), Social and Occupational Functioning Scale (SOFAS), and Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) before and after receiving fluoxetine or placebo. At baseline, the patients had impaired psychosocial functioning and markedly poor mental health-related quality of life. Compared to placebo, fluoxetine was associated with significantly greater improvement in LIFE-RIFT and SOFAS scores and with improvement on the mental health subscale of the SF-36 that approached significance. Decrease in the severity of body dysmorphic disorder, as measured by the Yale-Brown Obsessive Compulsive Scale Modified for Body Dysmorphic Disorder, was significantly correlated with improvement in functioning and quality of life.
References
Sep 1, 1991·The American Journal of Psychiatry·K A Phillips
Feb 10, 1988·Journal of Immunological Methods·B B Cohen
Jun 1, 1987·Archives of General Psychiatry·M B KellerN C Andreasen
Feb 1, 1985·Psychiatry Research·I W MillerH Maddever
Jun 1, 1981·The British Journal of Dermatology·J A Cotterill
Nov 1, 1994·Journal of Psychiatric Research·M G WarshawR L Stout
Feb 1, 1993·The American Journal of Psychiatry·K A PhillipsJ I Hudson
Aug 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·D VealeJ Walburn
Aug 1, 1997·The British Journal of Dermatology·J A Cotterill, W J Cunliffe
Oct 6, 1997·The Journal of Nervous and Mental Disease·K A Phillips, S F Diaz
Apr 17, 1998·Medical Care·G E SimonM Vonkorff
Dec 23, 1998·The Journal of Clinical Psychiatry·I W MillerM B Keller
Jul 27, 1999·Archives of Family Medicine·G E SimonE Wagner
Sep 3, 1999·Psychological Medicine·A C LeonM B Keller
Oct 9, 1999·General Hospital Psychiatry·R SturmW Katon
Nov 24, 1999·Archives of General Psychiatry·E HollanderD Simeon
Apr 5, 2000·The Journal of Nervous and Mental Disease·K A Phillips
Dec 26, 2001·JAMA : the Journal of the American Medical Association·K KroenkeM Weinberger
Jan 30, 2002·Psychosomatics·K A PhillipsR S Albertini
Feb 13, 2002·The Journal of Clinical Psychiatry·Mark H RapaportCathryn M Clary
Apr 3, 2002·Archives of General Psychiatry·Katharine A PhillipsSteven A Rasmussen
Jun 26, 2003·The Journal of Clinical Psychiatry·Katharine A Phillips, Fedra Najjar
Aug 19, 2003·Comprehensive Psychiatry·John Gunstad, Katharine A Phillips
Apr 27, 2004·CNS Spectrums·Katharine A Phillips
Apr 27, 2004·CNS Spectrums·Fugen Neziroglu, Sony Khemlani-Patel
Citations
Sep 4, 2012·CNS Spectrums·Waguih William IsHakKimberly M Ponton
Nov 15, 2006·Plastic and Reconstructive Surgery·Canice E CrerandDavid B Sarwer
Mar 4, 2014·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Brooke CollinsSabine Girod
May 14, 2011·Psychosomatics·Luana MarquesSabine Wilhelm
Jul 1, 2010·Psychiatric Annals·Katharine A Phillips
Oct 31, 2008·Comprehensive Psychiatry·Elizabeth R DidieKatharine A Phillips
Mar 8, 2008·Body Image·Katharine A Phillips, Eric Hollander
May 18, 2006·Behavioral Sciences & the Law·Douglas A Smith, Peter F Buckley
Sep 24, 2005·Comprehensive Psychiatry·Katharine A PhillipsMaria E Pagano
Apr 2, 2008·Journal of Psychiatric Research·Katharine A PhillipsRobert L Stout
Feb 1, 2017·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Sourav Khanra, Sourav Das
Aug 14, 2018·Current Neuropharmacology·Antonio Del CasaleMaurizio Pompili
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Jonathan C IpserDan J Stein
Jul 19, 2018·Endocrine·M VermalleF Castinetti
Jun 6, 2009·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Arun V RavindranNeil A Rector
May 12, 2012·Journal of Child Sexual Abuse·Gerard A SchaeferChristian Bahls